(Q33841403)

29 July 2017

1 reference

title

Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity (English)

1 reference

29 July 2017

1 reference

1 reference

H Montaudié

1

1 reference

29 July 2017

E Sbidian

2

1 reference

29 July 2017

C Paul

3

1 reference

29 July 2017

A Maza

4

1 reference

29 July 2017

A Gallini

5

1 reference

29 July 2017

S Aractingi

6

1 reference

29 July 2017

F Aubin

7

1 reference

29 July 2017

H Bachelez

8

1 reference

29 July 2017

B Cribier

9

1 reference

29 July 2017

P Joly

10

1 reference

29 July 2017

D Jullien

11

1 reference

29 July 2017

M Le Maître

12

1 reference

29 July 2017

L Misery

13

1 reference

29 July 2017

M-A Richard

14

1 reference

29 July 2017

J-P Ortonne

15

1 reference

29 July 2017

language of work or name

1 reference

1 May 2011

1 reference

Journal of the European Academy of Dermatology and Venereology

29 July 2017

1 reference

29 July 2017

25 Suppl 2

1 reference

29 July 2017

12-18

1 reference

Methotrexate guidelines--revised

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Methotrexate in psoriasis: consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03991.X

10.1111/J.1468-3083.2011.03991.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference